On Oct 25, 2021 Onconano Medicine closed a Series B round and raised $18,400,000 from Cancer Prevention and Research Institute of Texas, featuring lead investors Cancer Prevention and Research Institute of Texas.
About the company: Onconano Medicine is located at United States, North America.
“”
Company website: http://www.onconano.com